191 related articles for article (PubMed ID: 34838280)
1. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.
Berkman AM; Murphy KM; Siembida EJ; Lau N; Geng Y; Parsons SK; Salsman JM; Roth ME
Value Health; 2021 Dec; 24(12):1820-1827. PubMed ID: 34838280
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
Roth ME; Parsons SK; Ganz PA; Wagner LI; Hinds PS; Alexander S; Bingen K; Bober SL; Brackett J; Cella D; Henry NL; Indelicato DJ; Johnson RH; Miller TP; Rosenberg SM; Schmitz KH; Thanarajasingam G; Reeve BB; Salsman JM
J Natl Cancer Inst; 2023 Jan; 115(1):21-28. PubMed ID: 36266760
[TBL] [Abstract][Full Text] [Related]
3. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of health-related quality of life outcomes in psychosocial intervention trials for adolescent and young adult cancer survivors.
Murphy KM; Siembida E; Lau N; Berkman A; Roth M; Salsman JM
Crit Rev Oncol Hematol; 2023 Aug; 188():104045. PubMed ID: 37269881
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).
Mercieca-Bebber R; Williams D; Tait MA; Roydhouse J; Busija L; Sundaram CS; Wilson M; Langford A; Rutherford C; Roberts N; King M; Vodicka E; Devine B;
Qual Life Res; 2018 Oct; 27(10):2581-2591. PubMed ID: 29915979
[TBL] [Abstract][Full Text] [Related]
7. Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.
Jia Y; Li Q; Zhang X; Yan Y; Yan S; Li S; Li W; Wu X; Rong H; Liu J
J Med Internet Res; 2024 May; 26():e45719. PubMed ID: 38718388
[TBL] [Abstract][Full Text] [Related]
8. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
[TBL] [Abstract][Full Text] [Related]
9. Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.gov.
Lai-Kwon J; Yin Z; Minchom A; Yap C
Cancer Med; 2021 Nov; 10(22):7943-7957. PubMed ID: 34676991
[TBL] [Abstract][Full Text] [Related]
10. Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.
Giesinger JM; Efficace F; Aaronson N; Calvert M; Kyte D; Cottone F; Cella D; Gamper EM
Value Health; 2021 Apr; 24(4):585-591. PubMed ID: 33840437
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
12. The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials.
Coleman RL; Beck JT; Baranda JC; Jacobs I; Smoyer KE; Lee LJ; Askerova Z; McGinnis J; Ganti AK
Oncology; 2021; 99(7):444-453. PubMed ID: 33823518
[TBL] [Abstract][Full Text] [Related]
13. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Patient-Reported Outcome Measures for Use as Performance Metrics in Adolescent and Young Adult Psychosocial Cancer Care.
Rae CS; Tsangaris E; Klassen AF; Breakey V; D'Agostino N
J Adolesc Young Adult Oncol; 2020 Apr; 9(2):262-270. PubMed ID: 31682176
[No Abstract] [Full Text] [Related]
16. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
17. Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis.
Steinberg BA; Dorian P; Anstrom KJ; Hess R; Mark DB; Noseworthy PA; Spertus JA; Piccini JP
JACC Clin Electrophysiol; 2019 May; 5(5):599-605. PubMed ID: 31122382
[TBL] [Abstract][Full Text] [Related]
18. Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study.
Shnorhavorian M; Doody DR; Chen VW; Hamilton AS; Kato I; Cress RD; West M; Wu XC; Keegan THM; Harlan LC; Schwartz SM;
Am J Clin Oncol; 2018 Jun; 41(6):581-587. PubMed ID: 27635619
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
20. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
